PTC Therapeutics Launches Trial Testing Vatiquinone in Children, Young Adults

Print Friendly, PDF & Email

PTC Therapeutics has launched a Phase 3 clinical trial to evaluate its investigational oral therapy vatiquinone ( PTC743 ) in children and young adults with Frederich’s ataxia (FA). The international trial had experienced earlier delays due to the COVID-19 pandemic . Called MOVE-FA ( NCT04577352 ), it is meant […]